As of 2025-06-09, the Relative Valuation of Acceleron Pharma Inc (XLRN) is (52.87) USD. This relative valuation is based on P/E multiples. With the latest stock price at 178.75 USD, the upside of Acceleron Pharma Inc based on Relative Valuation is -129.6%.
The range of the Relative Valuation is (51.07) - (51.92) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.1x - 13.8x | 13.0x |
| Forward P/E multiples | 11.9x - 12.3x | 12.1x |
| Fair Price | (51.07) - (51.92) | (52.87) |
| Upside | -128.6% - -129.0% | -129.6% |
| Date | P/E |